Invention Grant
- Patent Title: Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions
-
Application No.: US15039650Application Date: 2014-11-26
-
Publication No.: US10562882B2Publication Date: 2020-02-18
- Inventor: Anne Goldby , Kerry Jenkins , Martin Teall
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Barnes & Thornburg LLP
- Agent Scott Rothenberger
- Priority: GB1320905.1 20131127
- International Application: PCT/GB2014/053499 WO 20141126
- International Announcement: WO2015/079224 WO 20150604
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D401/04
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R1, R2, R3, R4 and R5 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Public/Granted literature
- US20170166553A1 Piperidine Derivatives for Use in the Treatment or Prevention of Psychiatric and Neurological Conditions Public/Granted day:2017-06-15
Information query
